CD8A and cancer: From what is discussed above, it can be concluded that the infiltration and activity of CD8+ T cells can be used as a biomarker of response in cancer patients with SARS-CoV-2-induced diseases, and their dysfunctionality is a dominant reason for a more severe condition.